• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过系统评估体外预处理提高人诱导多能干细胞衍生心肌细胞的缺氧抗性用于心脏再生疗法。

Advancing Human iPSC-Derived Cardiomyocyte Hypoxia Resistance for Cardiac Regenerative Therapies through a Systematic Assessment of In Vitro Conditioning.

机构信息

Institute for Biology, Engineering and Medicine, School of Engineering, Brown University, Providence, RI 02912, USA.

出版信息

Int J Mol Sci. 2024 Sep 5;25(17):9627. doi: 10.3390/ijms25179627.

DOI:10.3390/ijms25179627
PMID:39273573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11395605/
Abstract

Acute myocardial infarction (MI) is a sudden, severe cardiac ischemic event that results in the death of up to one billion cardiomyocytes (CMs) and subsequent decrease in cardiac function. Engineered cardiac tissues (ECTs) are a promising approach to deliver the necessary mass of CMs to remuscularize the heart. However, the hypoxic environment of the heart post-MI presents a critical challenge for CM engraftment. Here, we present a high-throughput, systematic study targeting several physiological features of human induced pluripotent stem cell-derived CMs (hiPSC-CMs), including metabolism, Wnt signaling, substrate, heat shock, apoptosis, and mitochondrial stabilization, to assess their efficacy in promoting ischemia resistance in hiPSC-CMs. The results of 2D experiments identify hypoxia preconditioning (HPC) and metabolic conditioning as having a significant influence on hiPSC-CM function in normoxia and hypoxia. Within 3D engineered cardiac tissues (ECTs), metabolic conditioning with maturation media (MM), featuring high fatty acid and calcium concentration, results in a 1.5-fold increase in active stress generation as compared to RPMI/B27 control ECTs in normoxic conditions. Yet, this functional improvement is lost after hypoxia treatment. Interestingly, HPC can partially rescue the function of MM-treated ECTs after hypoxia. Our systematic and iterative approach provides a strong foundation for assessing and leveraging in vitro culture conditions to enhance the hypoxia resistance, and thus the successful clinical translation, of hiPSC-CMs in cardiac regenerative therapies.

摘要

急性心肌梗死(MI)是一种突发的严重心肌缺血事件,可导致多达十亿个心肌细胞(CMs)死亡,并随后导致心脏功能下降。工程化心脏组织(ECTs)是一种很有前途的方法,可以提供必要数量的 CMs 来使心脏重新肌肉化。然而,MI 后心脏的缺氧环境对 CM 移植提出了一个关键挑战。在这里,我们进行了一项高通量、系统性的研究,针对人诱导多能干细胞衍生的心肌细胞(hiPSC-CMs)的几个生理特征,包括代谢、Wnt 信号、基质、热休克、细胞凋亡和线粒体稳定,以评估它们在促进 hiPSC-CM 缺血抗性方面的功效。2D 实验结果表明,缺氧预处理(HPC)和代谢条件对 hiPSC-CM 在常氧和缺氧条件下的功能有显著影响。在 3D 工程化心脏组织(ECTs)中,用富含脂肪酸和钙的成熟培养基(MM)进行代谢条件处理,与 RPMI/B27 对照 ECTs 相比,在常氧条件下可使活性应激生成增加 1.5 倍。然而,这种功能改善在缺氧处理后消失了。有趣的是,HPC 可以部分挽救 MM 处理的 ECTs 在缺氧后的功能。我们的系统和迭代方法为评估和利用体外培养条件提供了坚实的基础,以增强 hiPSC-CMs 的缺氧抗性,从而成功地将其应用于心脏再生治疗中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b637/11395605/76b25c0ac806/ijms-25-09627-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b637/11395605/bbe072adb985/ijms-25-09627-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b637/11395605/554acb3f55cd/ijms-25-09627-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b637/11395605/aeea6b5974f4/ijms-25-09627-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b637/11395605/761e871bcf27/ijms-25-09627-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b637/11395605/06400a36f19d/ijms-25-09627-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b637/11395605/76b25c0ac806/ijms-25-09627-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b637/11395605/bbe072adb985/ijms-25-09627-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b637/11395605/554acb3f55cd/ijms-25-09627-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b637/11395605/aeea6b5974f4/ijms-25-09627-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b637/11395605/761e871bcf27/ijms-25-09627-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b637/11395605/06400a36f19d/ijms-25-09627-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b637/11395605/76b25c0ac806/ijms-25-09627-g006.jpg

相似文献

1
Advancing Human iPSC-Derived Cardiomyocyte Hypoxia Resistance for Cardiac Regenerative Therapies through a Systematic Assessment of In Vitro Conditioning.通过系统评估体外预处理提高人诱导多能干细胞衍生心肌细胞的缺氧抗性用于心脏再生疗法。
Int J Mol Sci. 2024 Sep 5;25(17):9627. doi: 10.3390/ijms25179627.
2
Thymosin β4 increases cardiac cell proliferation, cell engraftment, and the reparative potency of human induced-pluripotent stem cell-derived cardiomyocytes in a porcine model of acute myocardial infarction.胸腺素 β4 可增加心肌细胞的增殖、细胞植入和人诱导多能干细胞衍生的心肌细胞在猪急性心肌梗死模型中的修复能力。
Theranostics. 2021 Jun 26;11(16):7879-7895. doi: 10.7150/thno.56757. eCollection 2021.
3
Stimulating Calcium Handling in hiPSC-Derived Engineered Cardiac Tissues Enhances Force Production.刺激 hiPSC 衍生的工程化心脏组织中的钙处理可增强肌力产生。
Stem Cells Transl Med. 2022 Mar 3;11(1):97-106. doi: 10.1093/stcltm/szab002.
4
N-cadherin overexpression enhances the reparative potency of human-induced pluripotent stem cell-derived cardiac myocytes in infarcted mouse hearts.N-钙黏蛋白过表达增强了人诱导多能干细胞衍生的心肌细胞在梗死小鼠心脏中的修复能力。
Cardiovasc Res. 2020 Mar 1;116(3):671-685. doi: 10.1093/cvr/cvz179.
5
Human iPSC-engineered cardiac tissue platform faithfully models important cardiac physiology.人诱导多能干细胞工程化心脏组织平台忠实地模拟了重要的心脏生理学。
Am J Physiol Heart Circ Physiol. 2021 Apr 1;320(4):H1670-H1686. doi: 10.1152/ajpheart.00941.2020. Epub 2021 Feb 19.
6
Laminin-221 Enhances Therapeutic Effects of Human-Induced Pluripotent Stem Cell-Derived 3-Dimensional Engineered Cardiac Tissue Transplantation in a Rat Ischemic Cardiomyopathy Model.层粘连蛋白 221 增强人诱导多能干细胞衍生的三维工程化心脏组织移植在大鼠缺血性心肌病模型中的治疗效果。
J Am Heart Assoc. 2020 Aug 18;9(16):e015841. doi: 10.1161/JAHA.119.015841. Epub 2020 Aug 12.
7
Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction.急性心肌梗死后人诱导多能干细胞衍生心肌细胞与人间充质干细胞的比较。
PLoS One. 2014 Dec 31;9(12):e116281. doi: 10.1371/journal.pone.0116281. eCollection 2014.
8
Combined Treatment of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Endothelial Cells Regenerate the Infarcted Heart in Mice and Non-Human Primates.人诱导多能干细胞衍生的心肌细胞和内皮细胞的联合治疗可在小鼠和非人类灵长类动物的梗死心脏中再生。
Circulation. 2023 Oct 31;148(18):1395-1409. doi: 10.1161/CIRCULATIONAHA.122.061736. Epub 2023 Sep 21.
9
Patterned Arteriole-Scale Vessels Enhance Engraftment, Perfusion, and Vessel Branching Hierarchy of Engineered Human Myocardium for Heart Regeneration.模式化的微动脉-微血管分级结构增强了工程化人心肌的植入、灌注和血管分支结构,有助于心脏再生。
Cells. 2023 Jun 23;12(13):1698. doi: 10.3390/cells12131698.
10
CHIR99021 and fibroblast growth factor 1 enhance the regenerative potency of human cardiac muscle patch after myocardial infarction in mice.CHIR99021 和成纤维细胞生长因子 1 增强了心肌梗死后小鼠人心肌补丁的再生能力。
J Mol Cell Cardiol. 2020 Apr;141:1-10. doi: 10.1016/j.yjmcc.2020.03.003. Epub 2020 Mar 10.

引用本文的文献

1
Cardiomyocytes in Hypoxia: Cellular Responses and Implications for Cell-Based Cardiac Regenerative Therapies.缺氧状态下的心肌细胞:细胞反应及其对基于细胞的心脏再生疗法的影响
Bioengineering (Basel). 2025 Feb 6;12(2):154. doi: 10.3390/bioengineering12020154.

本文引用的文献

1
Hypoxic extracellular vesicles from hiPSCs protect cardiomyocytes from oxidative damage by transferring antioxidant proteins and enhancing Akt/Erk/NRF2 signaling.缺氧细胞外囊泡通过传递抗氧化蛋白和增强 Akt/Erk/NRF2 信号来保护心肌细胞免受氧化损伤。
Cell Commun Signal. 2024 Jul 9;22(1):356. doi: 10.1186/s12964-024-01722-7.
2
Metabolic Control of Cardiomyocyte Cell Cycle.心肌细胞细胞周期的代谢控制。
Methodist Debakey Cardiovasc J. 2023 Nov 16;19(5):26-36. doi: 10.14797/mdcvj.1309. eCollection 2023.
3
Intramyocardial injection of hypoxia-conditioned extracellular vesicles modulates apoptotic signaling in chronically ischemic myocardium.
心肌内注射缺氧预处理的细胞外囊泡可调节慢性缺血心肌中的凋亡信号。
JTCVS Open. 2023 Jun 20;15:220-228. doi: 10.1016/j.xjon.2023.05.013. eCollection 2023 Sep.
4
Pioneering therapies for post-infarction angiogenesis: Insight into molecular mechanisms and preclinical studies.心肌梗死后血管生成的开拓性治疗:对分子机制和临床前研究的深入了解。
Biomed Pharmacother. 2023 Oct;166:115306. doi: 10.1016/j.biopha.2023.115306. Epub 2023 Aug 10.
5
Patterned Arteriole-Scale Vessels Enhance Engraftment, Perfusion, and Vessel Branching Hierarchy of Engineered Human Myocardium for Heart Regeneration.模式化的微动脉-微血管分级结构增强了工程化人心肌的植入、灌注和血管分支结构,有助于心脏再生。
Cells. 2023 Jun 23;12(13):1698. doi: 10.3390/cells12131698.
6
Immature human engineered heart tissues engraft in a guinea pig chronic injury model.不成熟的人源工程心脏组织在豚鼠慢性损伤模型中移植。
Dis Model Mech. 2023 May 1;16(5). doi: 10.1242/dmm.049834. Epub 2023 Jun 5.
7
One Billion hiPSC-Cardiomyocytes: Upscaling Engineered Cardiac Tissues to Create High Cell Density Therapies for Clinical Translation in Heart Regeneration.十亿个人诱导多能干细胞来源的心肌细胞:扩大工程化心脏组织规模以创建用于心脏再生临床转化的高细胞密度疗法。
Bioengineering (Basel). 2023 May 13;10(5):587. doi: 10.3390/bioengineering10050587.
8
Therapeutic Hypothermia Inhibits Hypoxia-Induced Cardiomyocyte Apoptosis Via the MiR-483-3p/Cdk9 Axis.治疗性低温通过 miR-483-3p/Cdk9 轴抑制缺氧诱导的心肌细胞凋亡。
J Am Heart Assoc. 2023 Feb 21;12(4):e026160. doi: 10.1161/JAHA.122.026160. Epub 2023 Feb 15.
9
Comparative Analysis of Normoxia- and Hypoxia-Modified Extracellular Vesicle Therapy in Function, Perfusion, and Collateralization in Chronically Ischemic Myocardium.常氧和低氧修饰细胞外囊泡治疗慢性缺血性心肌功能、灌注和侧支血管形成的比较分析。
Int J Mol Sci. 2023 Jan 20;24(3):2076. doi: 10.3390/ijms24032076.
10
Proteomic Assessment of Hypoxia-Pre-Conditioned Human Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicles Demonstrates Promise in the Treatment of Cardiovascular Disease.蛋白质组学评估低氧预处理人骨髓间充质干细胞衍生的细胞外囊泡在心血管疾病治疗中的应用前景。
Int J Mol Sci. 2023 Jan 14;24(2):1674. doi: 10.3390/ijms24021674.